Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2.

TitleHyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2.
Publication TypeJournal Article
Year of Publication2021
AuthorsReiterer M, Rajan M, Gómez-Banoy N, Lau JD, Gomez-Escobar LG, Ma L, Gilani A, Alvarez-Mulett S, Sholle ET, Chandar V, Bram Y, Hoffman K, Bhardwaj P, Piloco P, Rubio-Navarro A, Uhl S, Carrau L, Houhgton S, Redmond D, Shukla AP, Goyal P, Brown KA, tenOever BR, Alonso LC, Schwartz RE, Schenck EJ, Safford MM, Lo JC
JournalCell Metab
Volume33
Issue12
Pagination2484
Date Published2021 Dec 07
ISSN1932-7420
DOI10.1016/j.cmet.2021.10.014
Alternate JournalCell Metab
PubMed ID34879241
PubMed Central IDPMC8650200
Grant ListR01 DK121140 / DK / NIDDK NIH HHS / United States
R01 CA234614 / CA / NCI NIH HHS / United States
R01 DK121844 / DK / NIDDK NIH HHS / United States
R01 DK121072 / DK / NIDDK NIH HHS / United States
UL1 TR002384 / TR / NCATS NIH HHS / United States
R01 CA215797 / CA / NCI NIH HHS / United States

Weill Cornell Medicine Friedman Center for Nutrition & Inflammation 413 E. 69th Street, Seventh Floor New York, NY 10021